Hippocratic AI acquisition marks push into life sciences
SAN FRANCISCO—Hippocratic AI is building out its life sciences division to accelerate generative and agentic artificial intelligence in the biopharma and medtech sectors. The company, which developed patient-facing generative AI healthcare agents, acquired Grove AI, a startup that offers agentic AI for pharma R&D and clinical trial operations. The company’s AI solutions aim to streamline…
